American International Group’s Transphorm, Inc. Common Stock TGAN Stock Holding History

American International Group’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,773	Closed	-$72.5K	–	2974
2024 Q1	$72.5K	Buy	14,773 +178	+1%	+$845	﹤0.01%	2674
2023 Q4	$53.3K	Buy	14,595 +552	+4%	+$1.51K	﹤0.01%	2802
2023 Q3	$31.2K	Buy	14,043 +1,031	+8%	+$2.88K	﹤0.01%	2926
2023 Q2	$44.2K	Buy	13,012 +2,031	+18%	+$7.33K	﹤0.01%	2912
2023 Q1	$43.8K	Buy	10,981 +218	+2%	+$960	﹤0.01%	2752
2022 Q4	$58.6K	Sell	10,763 -38	-0.4%	-$224	﹤0.01%	2701
2022 Q3	$54K	Buy	10,801 +764	+8%	+$3.76K	﹤0.01%	2792
2022 Q2	$38K	Buy	+10,037	New	+$64.1K	﹤0.01%	2930

American International Group's TGAN Position: Q2 2024 in Review

American International Group sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 14,773 shares — an estimated $72.5K sold.

American International Group first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $72.5K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

American International Group reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
American International Group sold 14,773 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $72.5K.
American International Group first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
American International Group's Transphorm, Inc. Common Stock position peaked at $72.5K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.